Detalhe da pesquisa
1.
Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer.
Br J Cancer
; 127(5): 927-936, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618789
2.
RB expression confers sensitivity to CDK4/6 inhibitor-mediated radiosensitization across breast cancer subtypes.
JCI Insight
; 7(3)2022 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34932500
3.
Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models.
NPJ Breast Cancer
; 8(1): 31, 2022 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35273179
4.
Publisher Correction: Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models.
NPJ Breast Cancer
; 8(1): 54, 2022 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35444242